Literature DB >> 6269279

Effects of reserpine treatment on beta-adrenergic/adenylate cyclase modulate secretion and resynthesis by the rat submandibular gland.

L S Cutler, J Boccuzzi, L Yaeger, B Bottaro, C P Christian, J R Martinez.   

Abstract

Chronic reserpine (adrenergic blocking) treatment causes a marked accumulation of secretory protein in the rat submandibular gland (SMG) but discharge of this material is delayed in response to isoproterenol stimulation. The purposes of this study were to investigate the effects of chronic reserpine treatment on 1) the number of beta-adrenergic receptor. 2) the sensitivity of cell-surface-associated adenylate cyclase to various concentrations of isoproterenol, and 3) to correlate these data to morphologic studies of the secretion and resynthesis phases of the isoproterenol-induced secretory cycle in the rat SMG. Animals were injected with reserpine (0.5 microgram/g b.w.) for 6 days. Plasma membrane fractions were prepared. The adenylate cyclase response to a series of isoproterenol concentrations, and the number of beta-adrenergic receptors ([3H]-alprenolol binding) were determined. Other animals were given a single dose of isoproterenol (0.8 mg/100 g b.w.) and the SMG was examined by light and electron microscopy at various times (30 min to 24 h) after treatment. Chronic reserpine treatment leads to a 2.5-fold increase in SMG beta-adrenergic binding sites and a 50-fold increase in adenylate cyclase sensitivity to IPR stimulation when compared to controls. However, secretion and resynthesis of secretory product in response to IPR stimulation was greatly delayed in reserpinized rats.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269279     DOI: 10.1007/bf00430820

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  29 in total

1.  Cytochemical localization of adenylate cyclase and of calcium ion, magnesium ion-activated ATPases in the dense tubular system of human blood platelets.

Authors:  L Cutler; G Rodan; M B Feinstein
Journal:  Biochim Biophys Acta       Date:  1978-09-06

2.  Denervation-induced changes in alpha and beta adrenergic receptors of the rat submandibular gland.

Authors:  C D Arnett; J N Davis
Journal:  J Pharmacol Exp Ther       Date:  1979-11       Impact factor: 4.030

3.  Elevated beta-adrenergic receptor number after chronic propranolol treatment.

Authors:  G Glaubiger; R J Lefkowitz
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

4.  Intercellular contacts at the epithelial-mesenchymal interface of the developing rat submandibular gland in vitro.

Authors:  L S Cutler
Journal:  J Embryol Exp Morphol       Date:  1977-06

Review 5.  The reserpine receptor.

Authors:  A Giachetti; P A Shore
Journal:  Life Sci       Date:  1978-07-10       Impact factor: 5.037

6.  Enzyme secretion mediated by the epinephrine -receptor in rat parotid slices. Factors governing efficiency of the process.

Authors:  S Batzri; Z Selinger
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

7.  [Sialadenosis of the parotid gland after long-term treatment with antihypertensive agents (Guanacline). Ultrastructural alterations].

Authors:  K Donath; G Seifert; W Pirsig
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1973

8.  Ultrastructural changes in the rat submaxillary gland following isoprenaline.

Authors:  J M Radley
Journal:  Z Zellforsch Mikrosk Anat       Date:  1969-05-23

9.  Secretory dynamics of the rat submandibular gland. An ultrastructural and cytochemical study of the isoproterenol-induced secretory cycle.

Authors:  B I Bogart
Journal:  J Ultrastruct Res       Date:  1975-08

10.  Salivary studies in cystic fibrosis.

Authors:  I D Mandel; A Kutscher; C R Denning; R H Thompson; E V Zegarelli
Journal:  Am J Dis Child       Date:  1967-04
View more
  1 in total

1.  Adenylate cyclase and beta-receptors in salivary glands of rats fed diets containing trans fatty acids.

Authors:  Y F Ren; S Q Alam; B S Alam; L M Keefer
Journal:  Lipids       Date:  1988-04       Impact factor: 1.880

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.